<DOC>
	<DOCNO>NCT01003028</DOCNO>
	<brief_summary>This study intend evaluate effect decrease maximum plasma concentration target remifentanil Target Controlled Infusion system incidence major minor side-effects .</brief_summary>
	<brief_title>Reduction Remifentanil-related Complications Limiting Maximum Plasma Concentration During Target-controlled Infusion</brief_title>
	<detailed_description />
	<mesh_term>Remifentanil</mesh_term>
	<criteria>1870 year old ASA class 13 schedule elective surgery history neurologic mental disorder uncontrolled pulmonary cardiovascular disease history adverse reaction opioids history drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Total intravenous anesthesia</keyword>
	<keyword>Maximum plasma concentration remifentanil</keyword>
</DOC>